Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic
Frontiers in Psychiatry · 06.04.2023 · 14
DOI: 10.3389/fpsyt.2023.1017203 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 06.04.2023. Verfasst von Yuanzhi Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Ningbo Kangning Hospital, Ningbo, Zhejiang, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Ningbo.
Themen: Depression
Abstract (Originalsprache)
Late-life depression (LLD) is one of the most common mental disorders among the older adults. Population aging, social stress, and the COVID-19 pandemic have significantly affected the emotional health of older adults, resulting in a worldwide prevalence of LLD. The clinical phenotypes between LLD and adult depression differ in terms of symptoms, comorbid physical diseases, and coexisting cognitive impairments. Many pathological factors such as the imbalance of neurotransmitters, a decrease in neurotrophic factors, an increase in β-amyloid production, dysregulation of the hypothalamic-pituitary-adrenal axis, and changes in the gut microbiota, are allegedly associated with the onset of LLD. However, the exact pathogenic mechanism underlying LLD remains unclear. Traditional selective serotonin reuptake inhibitor therapy results in poor responsiveness and side effects during LLD treatment. Neuromodulation therapies and complementary and integrative therapies have been proven safe and effective for the treatment of LLD. Importantly, during the COVID-19 pandemic, modern digital health intervention technologies, including socially assistive robots and app-based interventions, have proven to be advantageous in providing personal services to patients with LLD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ningbo Kangning Hospital, Ningbo, Zhejiang, China.
- Department of Neurology, Ningbo Rehabilitation Hospital, Ningbo, Zhejiang, China.
- Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, Translational Medicine Center of Pain, Emotion and Cognition, School of Medicine, Ningbo University, Ningbo, Zheji…
Förderung
- Natural Science Foundation of Ningbo
Zitieren
APA
Zhao, Y., Wu, X., Tang, M., Shi, L., Gong, S., Mei, X., Zhao, Z., He, J., Huang, L., & Cui, W. (2023). Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1017203
Vancouver
Zhao Y, Wu X, Tang M, Shi L, Gong S, Mei X, et al. Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1017203
BibTeX
@article{Zhao2023,
author = {Zhao, Yuanzhi and Wu, Xiangping and Tang, Min and Shi, Lingli and Gong, Shuang and Mei, Xi and Zhao, Zheng and He, Jiayue and Huang, Ling and Cui, Wei},
title = {Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic},
journal = {Frontiers in Psychiatry},
year = {2023},
volume = {14},
doi = {10.3389/fpsyt.2023.1017203}
}
EUVIMED